Skip to content
Screener

Arcturus Therapeutics ARCT Q1 2025 earnings

Reported May 12, 2025 · After market close

Revenue$29.4MBeat by $6.0M
EPS-$0.52Beat by $1.06
Revenue estimate$23.3M
EPS estimate-$1.58

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$8.0M
EPS estimate-$0.67

FAQ

When did Arcturus Therapeutics report Q1 2025 earnings?
Arcturus Therapeutics (ARCT) reported Q1 2025 earnings on May 12, 2025 after market close.
What were Arcturus Therapeutics's Q1 2025 revenue and EPS?
Arcturus Therapeutics reported revenue of $29.4M and eps of $-0.52 for Q1 2025.
Did Arcturus Therapeutics beat estimates in Q1 2025?
Revenue beat the consensus estimate of $23.3M by $6.0M. EPS beat the consensus estimate of $-1.58 by $1.06.
How did Arcturus Therapeutics's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 9.9% from $32.6M a year earlier and eps grew 48.0% from $-1.00.
Where can I find Arcturus Therapeutics's Q1 2025 SEC filings?
You can read the 8-K earnings release (0001193805-25-000630) and the 10-Q periodic report (0000950170-25-069210) directly on SEC EDGAR. The filing index links above go to sec.gov.